Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novartis Ag (NVS)
NYSE:NVS
Novartis (NVS) Stock Price & Analysis
3,325 Followers
NVS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$86.74 - $106.18
Previous Close$97.44
Volume2.17M
Average Volume (3M)1.63M
Market Cap
$193.77B
Enterprise Value$199.69B
Total Cash (Recent Filing)$14.43B
Total Debt (Recent Filing)$20.26B
Price to Earnings (P/E)13.1
Beta0.51
Next Earnings
Jul 18, 2024EPS Estimate
$1.83Last Dividend Ex-Date
Mar 07, 2024Dividend Yield3.23%
Share Statistics
EPS (TTM)7.42
Shares Outstanding2,044,033,986
10 Day Avg. Volume2,136,316
30 Day Avg. Volume1,626,833
Standard Deviation0.06
R-Squared0.21
Alpha-0.00103
Financial Highlights & Ratios
Price to Book (P/B)-56.06
Price to Sales (P/S)4.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.70
Enterprise Value/Gross Profit5.84
Enterprise Value/Ebitda24.33
Forecast
1Y Price Target
$114.67Price Target Upside18.11% Upside
Rating ConsensusHold
Number of Analyst Covering5
Novartis News
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyNovartis has financial capacity for strategic acquisitions that could enhance its portfolio and drive future growth.
Clinical PipelineNovartis maintains a clinical pipeline that includes label expansion efforts and the development of new molecular entities to offset upcoming loss of exclusivities.
Growth StrategyNovartis is well-positioned for long-term growth following the Sandoz spinoff.
Bears Say
Earnings ForecastTarget price implies modest upside to current levels, indicating limited growth potential in the near term.
Market CompetitionLow visibility into competitive dynamics for key products could lead to downward adjustments in future sales forecasts.
Stock ValuationThe analyst's target price implies modest upside from current levels, suggesting limited growth potential in the near term.
---
Ownership Overview
0.00%
Insiders
1.95% Mutual Funds
0.55% Other Institutional Investors
97.50% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVS FAQ
What was Novartis Ag’s price range in the past 12 months?
Novartis Ag lowest stock price was $86.74 and its highest was $106.18 in the past 12 months.
What is Novartis Ag’s market cap?
Currently, no data Available
When is Novartis Ag’s upcoming earnings report date?
Novartis Ag’s upcoming earnings report date is Jul 18, 2024 which is in 76 days.
How were Novartis Ag’s earnings last quarter?
Novartis Ag released its earnings results on Apr 23, 2024. The company reported $1.8 earnings per share for the quarter, beating the consensus estimate of $1.678 by $0.122.
Is Novartis Ag overvalued?
According to Wall Street analysts Novartis Ag’s price is currently Undervalued.
Does Novartis Ag pay dividends?
Novartis Ag pays a Annually dividend of $2.46 which represents an annual dividend yield of 3.23%. See more information on Novartis Ag dividends here
What is Novartis Ag’s EPS estimate?
Novartis Ag’s EPS estimate is $1.83.
How many shares outstanding does Novartis Ag have?
Novartis Ag has 2,189,930,400 shares outstanding.
What happened to Novartis Ag’s price movement after its last earnings report?
Novartis Ag reported an EPS of $1.8 in its last earnings report, beating expectations of $1.678. Following the earnings report the stock price went up 2.271%.
Which hedge fund is a major shareholder of Novartis Ag?
Among the largest hedge funds holding Novartis Ag’s share is Dodge & Cox. It holds Novartis Ag’s shares valued at 1B.
---
Novartis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$114.67 (18.11% Upside)
$114.67 (18.11% Upside)
Blogger Sentiment
Bullish
NVS Sentiment 84%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 4.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.48%
12-Months-Change
Fundamentals
Return on Equity
19.96%
Trailing 12-Months
Asset Growth
-15.95%
Trailing 12-Months
Company Description
Novartis Ag
Novartis AG develops, manufactures and sells healthcare products. Its two reporting segments are: Innovative Medicines and Sandoz. The Innovative Medicines business develops and sells patented prescription medicines and is made up of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
---
NVS Company Deck
---
NVS Earnings Call
Q1 2024
0:00 / 0:00
---
NVS Stock 12 Months Forecast
Average Price Target
$114.67
▲(18.11% Upside)
Technical Analysis
Best Analysts Covering NVS
1 Year
1 Year Success Rate
7/8 ratings generated profit
1 Year Average Return
+12.74%
reiterated a buy rating 7 months ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +12.74% per trade.
---